ACM
BCAX

Aquatic Capital Management’s Bicara Therapeutics BCAX Stock Holding History

Aquatic Capital Management’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538K Buy
+18,114
New +$404K 0.02% 771
2026
Q1 		– Sell
-11,127
Closed -$187K – 1888
2025
Q4 		$187K Buy
+11,127
New +$190K 0.01% 1015

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Aquatic Capital Management's BCAX Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 18,114 shares worth $538K. The stake represents 0.02% of the portfolio and ranks #771 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in BCAX as recently as Q4 2025.

Aquatic Capital Management first reported a position in BCAX in Q4 2025 and has held it in 2 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Aquatic Capital Management held 18,114 shares of Bicara Therapeutics worth $538K as of Q2 2026.
  • Bicara Therapeutics was a new Aquatic Capital Management position in Q2 2026.
  • Bicara Therapeutics made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #771 holding.
  • Aquatic Capital Management first reported a position in Bicara Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.